Which path will you take?
We discussed many of the far-reaching changes influencing the pharmaceutical and life sciences industry (Pharma) as it approaches the second decade of the new millennium in the previous four papers in the PricewaterhouseCoopers’ Pharma 2020 series. Our latest report focuses on the resulting opportunities and challenges from a tax perspective.
No translations found for key: PubContactName
No translations found for key: PubContactPhone
+30 210 6874059